Christopher J. Kirk serves as Executive at Kezar Life Sciences, Inc., where they oversee executive responsibilities. Since joining the company, Christopher J. Kirk has executed 5 insider transactions totaling $147.9K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jul 20, 2023 involved exercising options for 48,950 shares valued at $44.1K.
Christopher J. Kirk currently holds 431,348 shares of Kezar Life Sciences, Inc. (KZR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher J. Kirk has been a net buyer of KZR stock. They have purchased $147.9K and sold $0 worth of shares.
Christopher J. Kirk's most recent insider trade was on Jul 20, 2023, when they sold 48,950 shares at $0.90 per share.
Get notified when new Form 4 filings are submitted
| 33,060 |
| $0.90 |
| Discretionary |
| Feb 4, 2020 | KZR | $100.0K | Purchase | 38,461 | $2.60 | Discretionary |
| Aug 13, 2019 | KZR | $23.1K | Purchase | 5,000 | $4.61 | Discretionary |
| Aug 9, 2019 | KZR | $24.9K | Purchase | 5,000 | $4.97 | Discretionary |